Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan Enyedy

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Computer-Aided Molecular Design|October 21, 2015
The statistics of virtual screening and lead optimizationMark McGann, Anthony Nicholls, Istvan Enyedy
Drug Discovery Today. Technologies|January 24, 2014
Inhibitors of protein-protein interactions: new methodologies to tackle this challengeLaura Silvian, Istvan Enyedy, Gnanasambandam Kumaravel
Future Medicinal Chemistry|December 14, 2017
Molecular modeling and docking studies of the oxytocin receptorGloria Antobreh, Istvan Enyedy, Aina Westrheim Ravna
Current Pharmaceutical Design|October 23, 2012
Role of bivalent cations in structural stabilities of new drug targets--vaccinia-related kinases (VRK) from molecular dynamics simulationsTing Fu, Hong Ren, Jiajing Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 2, 2020
Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analoguesFarzane Kuresh Kashgari, Aina Ravna, Georg Sager, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2020
Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activatorsBin Ma, Brian Lucas, Andrew Capacci, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2009
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype AVirginia Roxas-Duncan, Istvan Enyedy, Vicki A Montgomery, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonistsTao Wang, Daliya Banerjee, Tonika Bohnert, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) InhibitorsZhili Xin, Martin K Himmelbauer, J Howard Jones, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Structure-based design of low-nanomolar PIM kinase inhibitorsAlexey Ishchenko, Lin Zhang, Jean-Yves Le Brazidec, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Computer-Aided Molecular Design|October 21, 2015
The statistics of virtual screening and lead optimizationMark McGann, Anthony Nicholls, Istvan Enyedy
Drug Discovery Today. Technologies|January 24, 2014
Inhibitors of protein-protein interactions: new methodologies to tackle this challengeLaura Silvian, Istvan Enyedy, Gnanasambandam Kumaravel
Future Medicinal Chemistry|December 14, 2017
Molecular modeling and docking studies of the oxytocin receptorGloria Antobreh, Istvan Enyedy, Aina Westrheim Ravna
Current Pharmaceutical Design|October 23, 2012
Role of bivalent cations in structural stabilities of new drug targets--vaccinia-related kinases (VRK) from molecular dynamics simulationsTing Fu, Hong Ren, Jiajing Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 2, 2020
Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analoguesFarzane Kuresh Kashgari, Aina Ravna, Georg Sager, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2020
Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activatorsBin Ma, Brian Lucas, Andrew Capacci, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2009
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype AVirginia Roxas-Duncan, Istvan Enyedy, Vicki A Montgomery, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonistsTao Wang, Daliya Banerjee, Tonika Bohnert, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) InhibitorsZhili Xin, Martin K Himmelbauer, J Howard Jones, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Structure-based design of low-nanomolar PIM kinase inhibitorsAlexey Ishchenko, Lin Zhang, Jean-Yves Le Brazidec, et al.
Pageof 3